Cytoprotective agent for peptic ulcer prevention in patients taking dual antiplatelet agents: A randomized, double-blind placebo-controlled trial.
Rapat PittayanonPanida PiyachaturawatRungsun RerknimitrPiyapan PrueksapanichSupakarn ChaitongratVorarit LertsuwunseriSuphot SrimahachotaVarocha MahachaiPublished in: Journal of gastroenterology and hepatology (2019)
Rebamipide is safe and may prevent peptic ulcers ≥ 5 mm in diameter or those with pigmented spots in patients receiving dual antiplatelets for 1 year (NCT02166008).